Press Release Archive

2020  2019  2018   2017
2016  2015
2014   2013
2012   2011 2010   2009
2008   2007


Stuttgart – Dr. Margaret Faul, Executive Director Process Development, AMGEN Inc., and Professor Shu Kobayashi are soon to join the editorial board of Science of Synthesis (SOS), the comprehensive, full-text resource for methods in synthetic organic chemistry. Shu Kobayashi is a professor at the University of Tokyo and one of the leading experts on chemical catalysis. He will replace long-time Science of Synthesis editorial board member Professor Masakatsu Shibasaki. Margaret Faul will bring her expertise in chemical process development and research methods in biotechnology to the new task.

Science of Synthesis is used by chemical experts in industry, research, and education as both an interactive online platform offering full-text as well as structure searches and a printed work. The ten members of the editorial board work closely with Thieme’s team of editors to provide researchers with easily searchable and accessible information on methods and procedures for all relevant compound classes.

Dr. Margaret Faul joins the Science of Synthesis editorial board as an expert in Process Research and Development with ample experience in industrial biotech research. As Executive Director Process Development at AMGEN Inc., a position she took over in 2003, she is responsible for the commercial process development and process characterization of all molecules in both the synthetic and biologic Amgen portfolio. Dr. Faul, who earned her PhD specializing in organic synthetic chemistry at Harvard University, leverages her technical experience to support programs across all stages of development from preclinical to commercialization, investing significant effort in evolving a chemistry culture focused on the implementation of greener and more sustainable chemical processes. Dr. Faul is a member of the Board of Directors of the International Consortium for Innovation and Quality in the Pharmaceutical Industry and Chair of the Enabling Technologies Consortium.

“Dr. Faul stands for the mission of SOS to serve the academic and the industrial synthesis community alike. Her research-oriented approach allowed her and her team to find creative yet practical and economically viable solutions for many challenging synthetic problems in drug development. Her biotechnology expertise will be an extra asset for Science of Synthesis,” said Professor Dr. Alois Fürstner, Managing Director at the Max-Planck-Institut für Kohlenforschung (Max-Planck-Institut for Coal Research), Mülheim on Ruhr, and editor-in-chief of Science of Synthesis.

Professor Shu Kobayashi shares Dr. Faul’s interest in environmental considerations and efficient organic syntheses. With his research group at the University of Tokyo, he has been developing reaction systems for which water is used as a substitute for harmful organic solvents. Professor Kobayashi has already contributed his valuable expertise as author and publisher of the Science of Synthesis volume “Water in Organic Synthesis”. In addition, he focuses on the development of polymer-immobilized metal catalysts that can be recovered and reused. His research has won him the Nagoya Silver Medal, the Prize of the Japan Society for the Promotion of Science, the Green Chemistry Minister of Education Award, and the Research Award of the Alexander von Humboldt Foundation. Professor Kobayashi will take over on the Science of Synthesis editorial board from his former University of Tokyo colleague, Professor Masakatsu Shibasaki in January 2018.

“Professor Kobayashi is one the world’s leading researchers in the field of chemical catalysis. His novel research approach has led him to sometimes unorthodox, yet highly practical solutions to key problems in synthetic chemistry. We are excited to have him on board come next year,” said Professor Dr. Alois Fürstner.

To learn more about the Science of Synthesis print and online editions, please visit 14-day free trials are available upon request.


About Thieme
Thieme Publishing Group is a medical and scientific publishing house employing more than 900 staff and maintaining offices in seven cities, including New York, Delhi, Rio and Stuttgart, Germany. Founded in 1886, the Thieme name has become synonymous with high quality and excellence in online and print publishing. Thieme publishes 150 peer-reviewed journals and more than 450 new books annually. The company has a rapidly growing array of web-based products in medicine and science. State-of-the-art online products include eNeurosurgery, Medlantis, Thieme E-Journals, Thieme Electronic Book Library, the medical student website and Thieme Teaching Assistant, an innovative web-based platform for faculty. For more information about Thieme, please visit

Press Contact

Mareike Bauner
Public Relations and Press Office
Thieme Publishing Group
Ruedigerstrasse 14
70469 Stuttgart
Tel: +49-711-8931-646
Fax: +49-711-8931-167
This email address is being protected from spambots. You need JavaScript enabled to view it.


Sign up and be the first to get exclusive offers, sales, events, and more!

Yes, I would like to receive email newsletters with the latest news and information on products and services from Thieme Medical Publishers, Inc and selected cooperation partners in medicine and science regularly (about once a week). I agree to the use and processing of my personal information for this purpose. I can opt out at any time by clicking the "unsubscribe" link at the end of each newsletter.

Further information about data processing and your corresponding rights.

*Required field; all other fields are voluntary. We only use this information to personally address you in your newsletter.